Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

0.34
BATS BZX Real-Time Price
As of 11:05am ET
 +0.0079 / +2.38%
Today’s Change
0.32
Today|||52-Week Range
1.55
-17.07%
Year-to-Date
No recent news for Vical Inc.

Today’s Trading

Previous close0.33
Today’s open0.33
Day’s range0.32 - 0.34
Volume120,210
Average volume (3 months)407,041
Market cap$30.4M
Dividend yield--
Data as of 11:05am ET, 02/09/2016

Growth & Valuation

Earnings growth (last year)+47.22%
Earnings growth (this year)+50.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+97.16%
P/E ratioNM
Price/Sales6.13
Price/Book0.58

Competitors

 Today’s
change
Today’s
% change
SPHSSophiris Bio Inc-0.02-1.18%
PPHMPPeregrine Pharmaceut...+0.15+0.72%
OGENOragenics Inc-0.04-4.33%
CASICASI Pharmaceuticals...+0.03+2.92%
Data as of 10:50am ET, 02/09/2016

Financials

Last reporting dateFebruary 9, 2016
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$15.2M
Annual profit (last year)-$16.5M
Net profit margin-108.38%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Vijay B. Samant
Vice President-
Vaccine Research
Lawrence Russell Smith
Corporate headquarters
San Diego, California

Forecasts

Partner Offers